News

Keep up to date on our latest product launches, news, and conference appearances.

June 28, 2021News, Scientific News

Furin & Cathepsin L: New Targets
for Covid-19 Drug Screening

Coronavirus disease 2019 (COVID-19) has become a huge and ongoing global health crisis, affecting the millions of people worldwide who have been infected and shutting down global economies. While vaccines are now being rolled out, treatments for patients who are suffering from
COVID-19 are still lacking. Key targets exist which scientists are focusing on as potential anti-virals which would be effective against this potentially deadly disease….

Full Article
January 28, 2021News, News Announcements

HLA class II typed cells to accelerate effective research on immunotherapies

We support effective research on immunotherapies by expanding the range of HLA-types provided for all Human Primary Cells and Blood & Stem Cells. In addition to the MHC class I genes HLA-A, -B, and -C, we now also offer 4-digit resolution for MHC class II genes HLA-DPA1/DPB1, -DQA1/DQB1, and -DRB1/DRB345.
The Human Leukocyte Antigen (HLA) system plays a fundamental role in the determination of histocompatibility between different individuals and regulation of the human immunity….

Full Article
Cell culture media and reagents with certification accepted worldwide
January 18, 2021News, News Announcements

PromoCell is now EXCiPACT™ GMP certified

We have successfully completed a comprehensive EXCiPACT™ audit that certifies PromoCell as a manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards. This means we can now provide tailor-made cell culture media and reagents based on your regulatory requirements….

Full Article